MAM
SPPI

Martingale Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Martingale Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-62,450
Closed -$228K – 1044
2019
Q4 		$228K Buy
62,450
+35,802
+134% +$289K ﹤0.01% 940
2019
Q3 		$222K Buy
26,648
+1,901
+8% +$15.4K ﹤0.01% 966
2019
Q2 		$214K Buy
+24,747
New +$221K ﹤0.01% 985

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Martingale Asset Management's SPPI Position: Q1 2020 in Review

Martingale Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 62,450 shares — an estimated $228K sold.

Martingale Asset Management first reported a position in SPPI in Q2 2019 and held it in 3 quarters. The position peaked at $228K in Q4 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Martingale Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Martingale Asset Management sold 62,450 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $228K.
  • Martingale Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and held it in 3 quarters.
  • Martingale Asset Management's Spectrum Pharmaceuticals Inc position peaked at $228K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Martingale Asset Management's 13F filing for Q1 2020, filed 11 May 2020.